Modular Bioprocessing System for Automated Cell Therapy

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing bioprocessing systems for cellular immunotherapies, such as CAR-T cell therapy, are hindered by high costs, inflexibility, and increased contamination risks due to extensive human handling and complex operations, which also lead to workflow bottlenecks and inefficiencies in manufacturing processes.

Innovation Solution

A modular bioprocessing system comprising distinct modules for cell enrichment, activation, genetic modification, and expansion, allowing for automated and parallel processing of multiple samples, reducing human intervention and enhancing flexibility and consistency in volume production.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If extensive human handling and complex operations are used in existing bioprocessing systems, then flexibility in process customization is maintained, but contamination risk increases and manufacturing efficiency decreases

Engineering Contradiction:
Improvecontamination riskVSAvoidhuman handling
Core Design Contradiction:
ReliabilityVSExtent of automation

Solution Approach 1:

The bioprocessing system is divided into multiple isolated modules (enrichment module, activation module, expansion module, harvesting module) that can be independently operated. Each module performs a specific function with dedicated equipment, minimizing cross-contamination risks while maintaining process flexibility through modular configuration.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The system incorporates automated cell processing capabilities where cells are automatically transferred between modules using closed systems and automated liquid handling. The modules self-regulate process parameters and maintain sterile barriers without requiring manual intervention, reducing contamination risk while preserving process customization through programmable control.

Inventive Principle:
Principle #25Self-service

2Productivity

If multiple separate operations are performed sequentially in existing systems, then process control is maintained, but manufacturing time increases and productivity decreases

Engineering Contradiction:
Improvemanufacturing efficiencyVSAvoidmanufacturing time
Core Design Contradiction:
ProductivityVSLoss of time

Solution Approach 1:

The system enables continuous cell processing by eliminating idle time between operations. Cells are continuously transferred from enrichment to activation to expansion to harvesting through automated conveyance systems. Media and reagents are continuously supplied, and processed materials are continuously removed, maintaining uninterrupted productive action throughout the manufacturing process.

Inventive Principle:
Principle #20Continuity of useful action

Solution Approach 2:

Multiple processing operations that were previously performed sequentially in separate locations are merged into an integrated modular system where enrichment, activation, expansion, and harvesting occur in a coordinated sequence within the same facility. This consolidation eliminates transportation time and allows parallel processing of multiple cell types simultaneously.

Inventive Principle:
Principle #5Merging (Combining)

3Reliability

If highly specialized equipment is used to automate the manufacturing process, then contamination risk decreases, but system cost increases and flexibility is reduced

Engineering Contradiction:
Improvecontamination riskVSAvoidsystem cost
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The modular bioprocessing system uses standardized equipment configurations that can perform multiple functions across different modules. For example, automated liquid handlers are used for media addition, cell transfer, and reagent mixing in various modules. This universal equipment approach reduces overall system cost compared to specialized equipment for each operation while maintaining automated contamination control.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The system incorporates disposable sterile barriers and single-use bioreactors in each module that eliminate the need for expensive sterilization equipment and complex cleaning validation systems. These disposable components provide reliable contamination protection at lower cost by replacing expensive reusable equipment with affordable single-use alternatives.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

4Adaptability or versatility

If existing systems require customers to adapt their processes to particular equipment, then equipment standardization is achieved, but process flexibility and adaptability are lost

Engineering Contradiction:
Improveprocess flexibilityVSAvoidequipment adaptability
Core Design Contradiction:
Adaptability or versatilityVSEase of operation

Solution Approach 1:

The modular system features programmable control that allows process parameters, transfer rates, and operational sequences to be dynamically adjusted for different cell types and therapeutic protocols. Each module can be independently programmed to handle specific cell characteristics, enabling the system to adapt to various processes without requiring physical reconfiguration or customer process adaptation.

Inventive Principle:
Principle #15Dynamics

Data Source

PatentUS20240132826A1Bioprocessing apparatus
Publication Date: 2024.04.25 GLOBAL LIFE SCIENCES SOLUTIONS USA LLC
  • US20240132826A1 patent drawing
  • US20240132826A1 patent drawing
  • US20240132826A1 patent drawing

AI summary

An apparatus for bioprocessing includes a housing, a drawer receivable within the housing, the drawer including a plurality of sidewalls and a bottom defining a processing chamber, and a generally open top, the drawer being movable between a closed position in which the drawer is received within the housing, and an open position in which the drawer extends from the housing enabling access to the processing chamber through the open top, and at least one bed plate positioned within the processing chamber and configured to receive a bioreactor vessel.